Correlation Between Inozyme Pharma and Cocrystal Pharma
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Cocrystal Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Cocrystal Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Cocrystal Pharma, you can compare the effects of market volatilities on Inozyme Pharma and Cocrystal Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Cocrystal Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Cocrystal Pharma.
Diversification Opportunities for Inozyme Pharma and Cocrystal Pharma
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Inozyme and Cocrystal is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Cocrystal Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cocrystal Pharma and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Cocrystal Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cocrystal Pharma has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Cocrystal Pharma go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Cocrystal Pharma
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Cocrystal Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 1.59 times less risky than Cocrystal Pharma. The stock trades about -0.38 of its potential returns per unit of risk. The Cocrystal Pharma is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 183.00 in Cocrystal Pharma on September 4, 2024 and sell it today you would earn a total of 24.00 from holding Cocrystal Pharma or generate 13.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 97.62% |
| Values | Daily Returns |
Inozyme Pharma vs. Cocrystal Pharma
Performance |
| Timeline |
| Inozyme Pharma |
| Cocrystal Pharma |
Inozyme Pharma and Cocrystal Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Cocrystal Pharma
The main advantage of trading using opposite Inozyme Pharma and Cocrystal Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Cocrystal Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will offset losses from the drop in Cocrystal Pharma's long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Cocrystal Pharma vs. RenovoRx | Cocrystal Pharma vs. Tempest Therapeutics | Cocrystal Pharma vs. Ikena Oncology | Cocrystal Pharma vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance |